PROTAC IRAK4 degrader-1 |
| Catalog No.GC62197 |
PROTAC IRAK4 분해자-1은 특허 US20190192668A1 화합물 I-210에서 추출한 Cereblon 기반 PROTAC 인터루킨-1 수용체 관련 키나제 4(IRAK4) 분해자로 0.01 및 0.1에서 20-50% 및 >50% IRAK4 분해를 만듭니다. OCI-LY-10 세포에서 각각 1μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2360533-90-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
PROTAC IRAK4 degrader-1 is a PROTAC interleukin-1 receptor-associated kinase 4 (IRAK4) degrader extracted from patent US20190192668A1 Compound I-210, makes 20-50%, and >50% IRAK4 degradation at 0.01, 0.1, and 1 μM in OCI-LY-10 cells, respectively[1].
[1]. Nello Mainolfi, et al. Irak degraders and uses thereof. US20190192668A1.
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *